La Rabta Hospital

Tunis 1007

1 studies enrolling now · 9 studies all time

What they study most

Amyloidosis, Chronic Spontaneous Urticaria, Crohn's Disease, Fucosidosis, Gaucher Disease, Type 1, Generalized Pustular Psoriasis, Isolated Sulfite Oxidase Deficiency, Molybdenum Cofactor Deficiency

Studies at this site

• A Long-Term Observational Study of Patients With Fucosidosis — Recruiting now
• Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study — Running, not enrolling
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) — Running, not enrolling
• A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis — Completed
• Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis — Completed
• Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease — Completed
• Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease — Completed
• A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies — Completed
• Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis — Completed